GeneDx
The AI engine Fit Assessment
BetaGeneDx enhances diagnosis and treatment processes in women's health through its genomic testing and actionable health insights.
Blurb
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
HQ Location
Stamford (United States)
Founded
2017
Employees
501 - 1000
Total funding raised
$2.94B
Funding Status
Post-IPO Equity, $150.00M, January 26, 2023
Subspaces
- Genomic and Genetic Testing
GeneDx is focused on delivering personalized, actionable insights that improve health outcomes. GeneDx sit at the intersection of diagnostics and data science, pairing decades of genomic expertise with an unmatched ability to interpret clinical data at scale.